AdvertisementFDA Expedites Treatment Of Seriously Ill COVID-19 Patients With Experimental PlasmaMarch 24, 2020Joe PalcafacebookEmailThe U.S. Food and Drug Administration announced that it will make it easier for an experimental plasma to be tried on patients with COVID-19. (AP)
